Company intelligence / Profile preview

Audacy

Ownership: Public · AUDAQ
Employees: ~6
Development stage: Other

Overview

Audacity Therapeutics is a public benefit biotech/pharma company focused on developing therapies and diagnostics for the 90% of patients without adequate care. The team consists of experienced drug developers with a history of FDA/EMA-approved products. The company's mission includes innovating business models for sustainable public health impact.

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Biotech

Financials

Market cap: $785.3K
Total revenue: $301.6M
Enterprise value: $221M

Beyond the preview

Go deeper on Audacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Audacy.

Explore the full profile